Evidence map›Paper›PMID 41014637›Full record

ArticleNucleic acids research2025

On metrics for subpopulation detection in single-cell and spatial omics data.

Siyuan Luo, Pierre-Luc Germain, Ferdinand von Meyenn, Mark D Robinson

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Siyuan LuoLaboratory of Nutrition and Metabolic Epigenetics, Department of Health Sciences and Technology, ETH Zurich, 8603, Zurich, Switzerland.ORCID 0009-0007-6404-3244
Pierre-Luc GermainDepartment of Molecular Life Sciences, University of Zurich, 8057, Zurich, Switzerland.ORCID 0000-0003-3418-4218
Ferdinand von MeyennLaboratory of Nutrition and Metabolic Epigenetics, Department of Health Sciences and Technology, ETH Zurich, 8603, Zurich, Switzerland.ORCID 0000-0001-9920-3075
Mark D RobinsonDepartment of Molecular Life Sciences, University of Zurich, 8057, Zurich, Switzerland.ORCID 0000-0002-3048-5518

Funding

European Research Council 803491Swiss National Science Foundation 200021_212940Swiss National Science Foundation 310030_204869swissuniversities P5 Phase B 23-36_14
6 · The paper itself

Abstract

Benchmarks are crucial to understanding the strengths and weaknesses of the growing number of tools for single-cell and spatial omics analysis. A key task is to distinguish subpopulations within complex tissues, where evaluation typically relies on external clustering validation metrics. Different metrics often lead to inconsistencies between rankings, highlighting the importance of understanding the behavior and biological implications of each metric. In this work, we provide a framework for systematically understanding and selecting validation metrics for single-cell data analysis, addressing tasks such as creating cell embeddings, constructing graphs, clustering, and spatial domain detection. Our discussion centers on the desirable properties of metrics, focusing on biological relevance and potential biases. Using this framework, we not only analyze existing metrics but also develop novel ones. Delving into domain detection in spatial omics data, we develop new external metrics tailored to spatially aware measurements. Additionally, a Bioconductor R package, poem, implements all the metrics discussed. While we focus on single-cell omics, much of the discussion is of broader relevance to other types of high-dimensional data.

Indexed as

GenomicsSingle-Cell AnalysisAlgorithmsCluster AnalysisHumansSoftware

Identifiers

PMID41014637
PMCPMC12476229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.